• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan

    Solvay Invests in Suanfarma’s Vanillin Production

    GNC Adds Products from The Honest Company, Hers, and Womaness
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan

    Solvay Invests in Suanfarma’s Vanillin Production

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

    Leaven Essential to Launch Branded Botanical Extracts to Global Markets
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan

    Experts Debate Role of Supplements in Improving Public Health in EU
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Experts Debate Role of Supplements in Improving Public Health in EU

    GNC Adds Products from The Honest Company, Hers, and Womaness

    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Sabinsa Corporation

    Xsto Solutions

    Verdure Sciences

    Aiya America, Inc. (Aiya Matcha)

    PhytoGaia Inc
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Sabinsa Corporation

    Xsto Solutions

    Verdure Sciences

    Aiya America, Inc. (Aiya Matcha)

    PhytoGaia Inc
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Pharmaceutical Manufacturing Equipment Trends

    Demand for flexibility remains the driving force behind equipment systems.

    Pharmaceutical Manufacturing Equipment Trends
    Related CONTENT
    • GNC Adds Products from The Honest Company, Hers, and Womaness
    • Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark
    • Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds
    • Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    • Cargill to Double Production of Tapioca Syrup
    By Kristin Brooks, Managing Editor, Contract Pharma03.03.21
    As drug development trends change, so too must manufacturing processes and equipment. Contract Pharma looks into how the pandemic has impacted equipment needs, the latest technologies being leveraged in manufacturing, as well as continued challenges and where advances have been made across digital technologies, cell and gene manufacture, single use technologies, and continuous manufacturing.

    Pharma & Biopharma Trends   
    Personalized medicines topped one-third of all new drug approvals in 2020 for the third time in the last four years, according to a recent report from The Personalized Medicine Coalition. The U.S. FDA approved 19 personalized therapies, one cell-based immunotherapy, and eight new diagnostic indications, accounting for 39% of the new drugs FDA approved last year.1

    Key among the trends driving equipment needs is the growing number of complex and specialized therapies produced in small quantities, as well as drug delivery of therapies administered at home. In addition to flexibility for customization, is greater automation and modularity to address changing needs.

    Raffaele Pace, engineering vice president of operations for Stevanato Group, said, “The shift to more specialized therapies and the broader array of injection and inhaler devices, present significantly different designs in terms of size, material and shape, and require a complete change in manufacturing processes. Vendors are called to meet this requirement by offering flexible equipment that can process small batch sizes and handle different container types on a single machine, or assemble several formats or even different devices on the same line.” 

    Modularity is also key. Pace noted, whether an organization needs to scale up to increase production capacity or scale down to mix smaller batches, manufacturing equipment must adapt.

    Containment technologies play a big role in equipment needs for today’s specialized therapies. Dr. Andreas Mattern, director of product management pharma at Syntegon, said, “Biotechnologically produced drugs for the treatment of cancer, autoimmune diseases, or rare diseases affecting only a small patient population, are increasingly being developed and call for ever smaller batch sizes and highly flexible equipment. This trend is accompanied by the need for the highest product quality and protective measures. Containment technologies are highly requested, not only for liquid fill-finish lines, but also increasingly for oral solid dosage (OSD) forms. Here, containment equipment has the very important task of protecting operators from increasingly toxic substances.”

    Personalized medicines, such as those to treat orphan diseases, continue to have a massive impact on the pharmaceutical industry, according to Jan Deininger, group communications manager at OPTIMA Packaging Group. “Each drug represents a particularly high financial value and is complex to produce, which challenges the technology in various ways, most importantly safety and automation. This also influences the requirements for filling and closing machines. Small batches require high system flexibility as well as fully automated and fully safeguarded processes. Under these conditions and with these technologies, even small, very valuable batches can be processed very efficiently.”

    Optimization of equipment is also increasingly important for drug manufacturers. In the area of tablet press technology, Frederick Murray, president of KORSCH America Inc., said, “The emphasis on Overall Equipment Effectiveness continues to be a major consideration. Tracking machine uptime, output, and yields, in addition to key quality attributes, improvement efforts around reducing change times, or permitting a single operator to monitor multiple machines, are key focus areas.” Murray added that most products have been validated across a defined speed range of the tablet press, but often, there is the potential to run at the maximum validated speed if the right steps are taken with optimizing the press setup.

    Needs Amid The Pandemic
    The urgent need to produce millions of vaccines in short order has placed heavy demands on the industry. Here, manufacturing optimization is needed, leveraging production innovations and new technologies to accelerate processes with maximum efficiency.

    To address this Herculean task, according to Massimiliano Cesarini, sales director, Romaco S.r.l., “As a manufacturer of packaging and process technology, the main issue is the increased demand for high-performance technology for the aseptic filling of vaccines. To help address this need, Romaco’s Macofar VF high-speed machine fills vials with pharmaceutical liquids and biotech products under advanced aseptic conditions.” The machine has a maximum filling speed of 24,000 vials per hour and is able to maintain cold chains during filling, which is necessary for some vaccines and other pharmaceutical liquids.

    Due to the pandemic, the requirements for a filling line are even higher. “It’s not enough that it’s fast during operation, it must also enable production to start as quickly as possible. For this reason, many vaccine producers are moving away from isolator technology and opting for equipment with an open RABS (Restricted Access Barrier System),” Cesarini said.

    With respect to the Macofar VF, for example, equipped with open RABS, the machine is ready for production in about half the time and the validation and qualification of the system can be completed faster as well, according to Cesarini.

    More than 1,800 COVID-19 vaccines and therapies are currently being investigated in over 4,000 clinical trials, and according to Mattern of Syntegon, “Existing lab and manufacturing capacities must accordingly be reallocated or rebuilt in record time. For contract manufacturers, this need has resulted in an order increase of at least 200% in the infectious disease segment in 2020 compared to 2019.”   

    Many producers and developers of vaccines and active ingredients for the treatment of COVID-19 are using formulation systems, filling lines for vials, and inspection machines. According to Mattern, “Our experience with biologics enables us to support the production of novel mRNA vaccines with cold filling. Inspection machines from Syntegon are already used in the production process of mRNA COVID-19 vaccines.”

    The pharma industry is often slow in adopting production innovations or new technologies, but the COVID-19 pandemic has put pressure on accelerating these processes, according to Pace of Stevanato Group. “Vendors face an unprecedented challenge and are implementing strategies that enable them to operate even more efficiently, shifting in some cases from a traditional sequential process to an agile and modular approach. By ensuring equipment and software compatibility and consistency early on, the ramp-up process is expedited and the risk of unforeseen disruptive factors significantly reduced. Additionally, equipment should be future-proof, allowing a transition to other products, if necessary. For inspection, for instance, flexibility also means incorporating versatile technologies on automatic machines—capable of analyzing the full range of defect scenarios,” Pace said.

    With respect to processing and packaging equipment, Michele Leonardi, sales manager, Packaging Division for MG America, said, “Throughout 2020 and now in early 2021, we have noted a surge in the need for vial packaging equipment, mostly associated with COVID-19 vaccines. Speed has become increasingly paramount. The market saw urgent needs for equipment available in just a matter of weeks, when such machinery typically takes months to deliver, install and validate.”

    The industry is also moving toward greater automation, as there are a number of compelling reasons to do so. According to Deborah Smook, vice president of marketing & business development for TurboFil Packaging Machines LLC, “From a quality standpoint, there’s no question that automation leads to greater consistency. Even if throughput doesn’t increase, there is less waste with a more consistent process. Of course, with the pandemic there are additional incentives, including maintaining social distance between equipment operators.”

    Equipment Innovation
    Where the industry is slow to adopt change due to strict regulatory and validation requirements, increasingly lingering technology trends, such as digitalization and Artificial Intelligence (AI), are being leveraged for a high degree of flexibility in manufacturing processes, and greater efficiency. 

    The use of robots in liquid filling operations reduces the risk of contamination through human contact, according to Mattern of Syntegon. “Machine operators no longer need to perform repetitive tasks, which makes processes safer, more precise, reproducible and validatable. In the future, more and more robotic solutions will be used; the boundaries will continue to shift due to decreasing costs and new technologies such as AI,” Mattern said.

    “According to recent studies, next-generation digital technologies can help reduce pharma manufacturing costs by up to 20%, improve quality, and increase flexibility2; and pharma companies are likely to invest significantly in AI and Big Data over the next two years3,” said Pace of Stevanato Group. “In our operations, the prominent applications include AI and Digital Twin.”

    Pace explained, AI technology applied to automated visual inspection machines can help reduce parameterization and production costs, support robust root analysis and move to a predictive method exploiting the large amounts of data collected.

    Digital twin consists of a virtual replica of physical manufacturing equipment that can be used to run simulations before actual machines are built. Pace said, “This technology can offer a lot of data and visibility on how to optimize processes in the drug delivery device assembly.”

    The support of digitalization technologies for filling and closing processes is being further extended, according to Deininger of OPTIMA. “Optima has implemented a project in which video monitoring of the processing operations is almost comprehensive. In the event of an error message, this allows the cause to be narrowed down in detail, analyzed, and possibly large parts of batches to be saved, which would otherwise be rejected in their entirety,” said Deininger.

    Advances & Obstacles
    While there have been significant advances in manufacturing innovation, certain challenges remain in the burgeoning area of Advanced Therapy Medicinal Products (ATMPs), based on genes, tissues or cells. Also, while Single Use Technologies (SUTs) are fast becoming the gold standard, and continuous production strategies make headway in OSD, certain obstacles remain.

    With a growing number of approved therapies offering impressive outcomes, cell therapies hold great promise, however, commercial manufacturing of these complex and costly therapies is a key challenge. Dr. Tania Pereira Chilima, deputy CTO at Univercells Technologies, said, “Cell and gene therapies continue to be challenging to develop processes that can scale-up through to commercial manufacturing because the technologies that exist are not purpose fit for the special needs of these advanced therapies. And while innovation is happening, companies are also looking to control the cost of goods sold (COGs) to reliably produce and deliver commercial volumes of drugs to the market. This requires technologies that are readily available and validated for use.”

    The costs for this form of therapy are still extremely high today and the production process is complex, noted Deininger of OPTIMA. “Pharmaceutical engineering is challenged to contribute solutions for efficient, cost-effective production and filling by further automating and optimally safeguarding the manufacturing and processing steps. Platforms specifically for cell and gene therapies are needed,” Deininger said. To that end, OPTIMA designed automated, modular and highly flexible machine platforms based on isolator technology that can be equipped with robotic functions.

    With respect to Single Use Technologies, Chilima said, “SUTs are increasingly being used across the industry because the flexibility they offer is a real advantage over stainless-steel. Though it was met with skepticism at first, SUTs have left the state of nascent technology to become a standard reference.” However, challenges to implementation can still be associated with these technologies—most notably their sourcing and supply chain, according to Chilima, noting lead times can be long, especially during the current pandemic.

    Lastly, in the field of continuous tablet production, significant technical advancements have been made, including in-line granulation, blending, compression, and coating, according to Murray of KORSCH America Inc. “The increased use of Process Analytical Technology (PAT) sensors and fully integrated control systems has increased the capability of these systems, however, validation execution and capital investment remain the key barriers,” said Murray. “The tablet press is a critical component in any continuous production line; however, the press control system must be fully integrated with the central line system to permit control of peripherals, override capability on the material feed and tablet discharge, and full integration of process parameters, including in-line NIR probes,” added Murray.

    As more and more linked and chained processes are being developed, the main challenge is automating the processes by connecting technologies from different suppliers to develop fully integrated processes, according to Chilima of Univercells Technologies. “In addition to this technical challenge, the integration of continuous quality control (QC) testing solutions remains a key point from a regulatory perspective for the industry,” said Chilima.

    While continuous manufacturing is an unbroken trend in OSD production, Syntegon has developed a different approach. Mattern explained, “As opposed to the common complex mass flow rate based approach, excipients and active ingredients are dosed as a discrete mass on both the Xelum production platform and the Xelum R&D unit. This makes it possible to dose even smallest amounts of APIs of less than 1% reliably.”

    According to Pace of Stevanato Group, this pandemic offered a vital lesson for the future: optimizing the engineering and manufacturing equipment process, integrating proof-of-value stages through tight cooperation with customers, and use of new technologies is possible. 


    Kristin Brooks is the Managing Editor of Contract Pharma. She can reached at KBrooks@RodmanMedia.com

    References
    1. Personalized Medicine Coalition, Personalized Medicine at FDA: The Scope & Significance of Progress in 2020, www.personalizedmedicinecoalition.org
    2. Bain & Company, Digital Manufacturing Is (Finally) Coming to Pharma, 2020
    3. GlobalData, Digital Transformation and Emerging Technology in the Healthcare Industry, 2020 Edition
    Related Searches
    • Medical Nutrition
    • Contract Manufacturing
    Related Knowledge Center
    • Medical Nutrition
    • Contract Manufacturing
    Suggested For You
    GNC Adds Products from The Honest Company, Hers, and Womaness GNC Adds Products from The Honest Company, Hers, and Womaness
    Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark
    Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds
    Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules
    Cargill to Double Production of Tapioca Syrup Cargill to Double Production of Tapioca Syrup
    Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure Quality Testing of CoQ10 and Quercetin Brands Sold on Amazon Finds Continued Failure
    Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients Open Book Extracts Completes Phase 1 of Toxicology, Safety Assessment for Cannabinoid Ingredients
    Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
    What to Expect Next Week at Vitafoods Europe 2022 What to Expect Next Week at Vitafoods Europe 2022
    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions
    Nutraceuticals for Men: Muscle Health and Performance Nutrition Nutraceuticals for Men: Muscle Health and Performance Nutrition
    Dietary Supplement Delivery Formats Offer Strong Appeal and Unique Challenges Dietary Supplement Delivery Formats Offer Strong Appeal and Unique Challenges
    Market Shifts in Joint and Muscle Health Market Shifts in Joint and Muscle Health
    Natural Alternatives International Appoints Aaron Starr Vice President for Carnosyn Brands Natural Alternatives International Appoints Aaron Starr Vice President for Carnosyn Brands
    Probiotic Combination Evidenced to Have Colic, GI Health Benefits in Infants Probiotic Combination Evidenced to Have Colic, GI Health Benefits in Infants

    Related Content

    • Breaking News | Dietary Supplements | Products | Women's Health
      GNC Adds Products from The Honest Company, Hers, and Womaness

      GNC Adds Products from The Honest Company, Hers, and Womaness

      Highlighting National Women’s Health Month, the company is adding 13 products to its shelves formulated for women across life’s stages.
      05.16.22

    • Breaking News | Industry & Market News | Quality & Safety | Testing
      Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark

      Walgreen’s Brand Vitamins and Supplements First to Carry UL Verified Mark

      The certification affirms that product ingredients are as listed on Nutrition Facts and Supplement Facts panels.
      05.16.22

    • Breaking News | Cognitive Function | Dietary Supplements | Research News | Vitamins | Weight Management/Weight Loss
      Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

      Tocotrienols May Aid Weight Loss and Cognitive Performance, Animal Study Finds

      Full-spectrum palm tocotrienols inhibited weight gain and surpassed the blood brain barrier in supplemented mice.
      05.16.22


    • Breaking News | Delivery & Dosage Technologies | Regulations | Supplier News | World Markets
      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Lonza Expands Capsugel Capsule Offering with Titanium Dioxide-Free, White Hard Gelatin Capsules

      Capsule provides a bright white color while meeting titanium dioxide-free requirements for foods in the EU.
      05.10.22

    • Breaking News | Functional Foods & Beverages | Industry & Market News | World Markets
      Cargill to Double Production of Tapioca Syrup

      Cargill to Double Production of Tapioca Syrup

      Sourced from the cassava plant, tapioca syrup is used in a wide range of food products.
      05.10.22

      Breaking News
      • FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements
      • Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
      • Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
      • Solvay Invests in Suanfarma’s Vanillin Production
      • GNC Adds Products from The Honest Company, Hers, and Womaness
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
      Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
      Solvay Invests in Suanfarma’s Vanillin Production
      Coatings World

      Latest Breaking News From Coatings World

      DIC’s Indian Subsidiary Begins Construction of Coating Resins Production Facility
      Celanese Declares Force Majeure on Acetyl Chain and Acetate Tow Products
      CPI Announces New Hybrid Professional Development Program for 2022
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      XACT ACE OK'ed for Robotic Ablation Probe Insertion, Steering
      Nonin Medical Appoints Five New Board Members
      Tivic Health Appoints CFO and Regulatory VP
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Grand Opening of Kodiak Sciences’ Bioconjugation Facility
      Vertex Expands Cell and Gene Therapy Footprint
      AffyXell Expands Manufacturing Partnership with GenScript ProBio
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Nu Skin Joins EcoBeautyScore Consortium
      Nails Inc Partners with Magnum, Expands Chocolate-Scented Nail Polish Line
      Aveda is Leaping Bunny Approved by Cruelty Free International
      Happi

      Latest Breaking News From Happi

      Eucerin Expands into US Sun Protection Market with New Sun Line
      Mielle Organics Appoints Entrepreneur Steve Pamon to Advisory Board
      Major US Retailers Form Charter To Mitigate Racially Biased Experiences in Stores
      Ink World

      Latest Breaking News From Ink World

      ProAmpac Facilities Secure Safety Awards 2022
      Ball Corporation Enters Agreement for New Wind Energy
      Essentra Packaging Invests in Landa S10 Nanographic Press
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Essentra Packaging invests in Landa Nanographic press
      Nazdar to manufacture VFP electronic ink for US Market
      SunDance moves into flexible packaging with HP Indigo
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      'Right' Hygiene Conference to be Held in June
      Freudenberg to Present Battery Pack and Liquid Absorbers at Battery Show
      H&V Appoints Vice President and General Counsel
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Exactech Earns Breakthrough Status for JointMedica's Polymotion Hip Resurfacing
      Orthotic Brace Suppliers Convicted in $6.5M Fraud Scheme
      GE Additive and Orchid Partner to Advance Scalable Metal 3D Printing
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Emerson Earns Third Consecutive 2022 ENERGY STAR Partner of the Year Award
      First Solar to Sell Japan Project Development, O&M Platforms to PAG Real Assets
      Jabil Strengthens Additive Manufacturing Offerings

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login